Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes. The post How One Startup Is Aiming to Replace Surgery…
Desde 2022, entre tantos otros mamíferos, ha habido más de 80 casos confirmados de gatos domésticos con gripe aviar: generalmente gatos de granero que vivían en granjas lecheras, gatos salvajes y mascotas que pasan tiempo al aire libre y probablemente la contrajeron al cazar roedores o aves silvestres enfermas. Ahora, un pequeño pero creciente número…
[Sponsored] The 2025 Benefits Sentiment Index finds that self-insured employers are shifting their positions on healthcare navigation, GLP-1 drugs and more. The post What Direction is Healthcare Navigation for Self-Insured Employers Moving? appeared first on MedCity News.
KFF estimates that, if Congress allows the enhanced premium tax credits to expire at the end of this year, ACA Marketplace enrollees on average would see their premium payments more than double next year, growing by 114%, from an average of $888 in 2025 to $1,904 in 2026,
When the catastrophic Los Angeles fires broke out, John Volckens suspected firefighters and residents were breathing toxic air from the burning homes, buildings, and cars, but it was unclear how much risk the public faced. So, the professor of environmental health at Colorado State University devised a plan to get answers. Volckens shipped 10 air…
Meyer and Wyse: “Medicaid Expansion Reduced Mortality”Cannon response: “If…[Medicare and Medicaid]…were drugs, regulators would pull them from the market” and “Randomized Controlled Trials of Medicare and Medicaid, Please”L.A. Times to use the Green Bay Packers ownership model?Obesity: Diet > ExercisePrivacy laws for brain data.
Bristol Myers Squibb is licensing global rights to a Philochem program in development for both diagnostic imaging and targeted treatment of prostate cancer. It follows the pharma giant’s entry into radiopharmaceuticals via the $4.1 billion acquisition of RayzeBio last year. The post Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to…
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers. The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.
This brief focuses on the stand-alone Medicare Part D prescription drug plan marketplace and its somewhat uncertain future, in light of recent trends in plan availability and the potential for another year of premium increases in 2026, in part depending on what the Trump administration decides to do with the temporary Part D premium stabilization…
That is the title of an interview with me in The Evidence Base out today with the subtitle Introducing generalized cost effectiveness analysis for a comprehensive value assessment. Below is an excerpt: What is this paper about? What is new in this paper?Our recent publication presents a comprehensive framework for evaluating the societal value of health technologies,…